Psilocybin vs. DMT: What Are The Differences?

• By Sam Woolfe
• Medically approved by Dr. Ben Medrano
• May 17, 2021June 16, 2026
• DMT magic mushrooms Psilocybin Articles psilocybin mushrooms psychedelic therapy
• With 4 comments

Last reviewed and updated: June 16, 2026.

Key Takeaways

Duration	DMT: 5–15 min peak (smoked); Psilocybin: 4–6 hours; Ayahuasca (DMT + MAOI): 4–6 hours
Intensity	DMT breakthrough doses are extremely intense and rapid; psilocybin unfolds gradually with more emotional texture
Route	DMT: smoked/vaporized or via ayahuasca brew (oral with MAOI); Psilocybin: oral (mushrooms or synthetic capsule)
Clinical evidence	Psilocybin: extensive Phase 2/2b trial data; DMT: early-stage, mostly observational; psilocybin leads by a wide margin
Legal status (U.S.)	Psilocybin: legal facilitated services in Oregon + Colorado; DMT: Schedule I with no state exceptions

Psilocybin (the active ingredient in magic mushrooms) and N,N-Dimethyltryptamine (DMT). Undoubtedly, two classic psychedelics with many chemical similarities. They both belong to the tryptamine family of psychedelics. Moreover, DMT also has a very similar chemical structure to psilocin. Some people report that this similarity extends to these compounds’ effects. However, there’s also more than one difference between psilocybin and DMT.

This article will outline some of the main differences between psilocybin and DMT. These differences can affect a user’s experience, so read on for all the info you need.

RELATED: What Is 4-ACO-DMT, And Is It Legal?

Psilocybin and DMT Differ In Duration

Psilocybin offers a medium-length psychedelic experience. This is both in synthetic form and in magic mushrooms. A psilocybin experience will generally last 4–8 hours. This duration will vary, depending on the dosage, of course. For comparison, LSD is a long-lasting psychedelic, lasting 12 hours and sometimes longer.

DMT, in contrast, is a brief experience typically lasting 5–20 minutes. It is much easier, therefore, to fit in a DMT experience into your normal day. The drug was dubbed the “businessman’s trip” during the 60’s for this reason. Psilocybin, by contrast, requires much more time to have the experience.

Interested in joining a Psychedelics Clinical Trial? Sign up here now and we will connect you with a clinical trial in your area when one becomes available.

They Have Different Routes Of Administration

The difference between psilocybin and DMT also extends to their routes of administration. Users take psilocybin in the form of dried mushrooms. These can be eaten whole, with food, ground up into a capsule, or made into a tea. In clinical trials, researchers administer synthetic psilocybin in the form of a pill.

When people use DMT, on the other hand, it is typically in its freebase form and so can be vaporized. People can vaporize DMT in different ways, such as using a bong for example. In this case, DMT is sandwiched between a herbal mixture, so as not to burn it. Other options include special vaporizers (like the Glass Vapor Genie) or an oil-burner.

DMT can also be snorted (insuflated.)

It is also possible to infuse DMT with smokeable herbs. Taken this way, it is known as changa, sometimes referred to as smokeable ayahuasca. This mixture allows users to smoke DMT in joints or in a bong.

In clinical studies with DMT, volunteers receive intravenous (IV) doses of the drug. Ths can be seen in Rick Strassman’s famous research in the 90s, for example. Vaporizing, smoking, and IV injections are all different DMT routes of administration whereas psilocybin is only taken orally.

RELATED: Here’s How to Make Changa

Psilocybin and DMT Occur Differently In Nature

Both psilocybin and DMT occur in nature but in different types of species. Psilocybin is found in various species of mushrooms. DMT is found in most general groups of plants, as well as in the human body. DMT is found in the blood, urine, and cerebrospinal fluid. Researchers have also detected the presence of DMT in the brains of rats.

As opposed to being synthesized in a lab, DMT is extracted from a plant. Mimosa hostilis is a common plant that people use to carry out the extraction of DMT. Indigenous Amazonian tribes and retreat centers also use the plant when making ayahuasca. Ayahuasca is a brew made with a DMT-containing plant and an MAOI-containing plant. The latter makes the DMT orally active. Psychotria viridis is another common DMT-containing plant used when making ayahuasca.

Ready to explore a new horizon in mental health? Try out the beta version of HealingChat, HealingMaps AI chatbot that takes all our vetted content, clinics and retreats to answer all your questions in a safe environment. Try the beta version now!

The Therapeutic Applications Of Both Differ

There is a growing body of research looking at the therapeutic uses of psilocybin. Studies show that psilocybin can be safe and effective in the treatment of:

• Major depression
• Treatment-resistant depression
• Smoking addiction
• Anxiety in patients with a terminal illness
• Cluster headaches

However, the same sorts of studies on the therapeutic use of DMT do not exist. However, a number of studies examining ayahuasca’s potential. Ayahuasca is particularly promising for mental health conditions and addiction. This does not extend to the isolated compound DMT. Imperial College London will carry out the first clinical trial of the use of DMT to treat depression, however.

Many researchers believe that the quality of the psychedelic experience determines its therapeutic effects. Specifically, quality indicates whether patients have a mystical experience or not . DMT can induce such experiences and may prove to be an effective antidepressant. But as it stands, the therapeutic applications of DMT and psilocybin differ greatly.

Psilocybin and DMT Have Very Different Histories

Psilocybin has a rich and long cultural history. DMT is very different in this respect (bar ayahuasca). The use of psilocybin dates back to pre-Columbian Mesoamerican cultures (as far back as 3000 BC). These mushrooms, such as Psilocybe mexicana, were used in religious ceremonies.

The use of DMT, however, only really took off in the 1960s. Vaporizing DMT is more of a modern phenomenon. This means that the drug hasn’t existed as a traditional substance for ceremonial use.

Also Read: What Are Golden Teachers Mushrooms, And Are They Legal?

Psilocybin and DMT’s Subjective Effects Differ

Lastly, there are a number of differences in subjective effects between psilocybin and DMT. These include the following:

• A DMT trip has a fast onset, whereas psilocybin comes on more gradually.
• Many users report that DMT produces a profound and deep experience. This happens without one’s sense of self being significantly altered. A psilocybin experience, in contrast, ego dissolution can easily take place.
• The presence of entities is a recurring feature with DMT. Indeed, more so than with psilocybin. For example, many participants in Strassman’s DMT research reported seeing entities — or “DMT elves“. These included elves, clowns, dwarves, imps, angels, reptiles, and mantises. In the clinical trials with psilocybin, conversely, reports of entities are less common.
• Psilocybin experiences can increase a connection to the earth and nature. DMT, however, has more cosmic effects and extraterrestrial themes.
• Psilocybin produces an introspective experience. These feature themes, thoughts, and memories relating to one’s life. DMT, in contrast, is usually not so personal.

As we can see, there are some notable ways psilocybin and DMT are different. Understanding these differences should help you prepare for these types of experiences. Some people prefer psilocybin over DMT, and vice versa. Others may appreciate both, yet feel that they each have their own time and place.

RELATED READING

• What Is Psychedelic Therapy? Here’s What The Research Says
• Psychedelics Show Promise For A Range Of Mental Health Concerns
• Microdosing LSD: What The Research Actually Shows

Frequently Asked Questions

Which is stronger — psilocybin or DMT?

This depends on how you define “strong.” DMT at a full breakthrough dose (typically 40–60mg smoked or vaporized) produces one of the most intense psychedelic experiences known — an immediate, immersive, often entity-filled experience that reaches its peak within 5–10 minutes. Psilocybin produces a longer, more gradual arc: the experience unfolds over 4–6 hours and tends to be more emotionally and psychologically textured, integrating personal reflection and perceptual shifts. Ayahuasca, which contains DMT alongside MAOIs that extend its duration to 4–6 hours, is sometimes considered comparable in overall intensity to a high-dose psilocybin experience. In clinical research contexts, psilocybin has far more published evidence and is generally considered more controllable and suitable for therapeutic protocols than smoked DMT.

How long does a psilocybin experience last compared to DMT?

This is one of the most practical differences between the two. Smoked or vaporized DMT produces a peak experience of 5–15 minutes, with full resolution within 30–45 minutes. It is one of the shortest-acting psychedelics known. Psilocybin, by contrast, produces effects lasting 4–6 hours, with onset beginning 20–60 minutes after ingestion. Ayahuasca (which contains DMT plus an MAOI that prevents rapid breakdown) lasts 4–6 hours, similar to psilocybin. The brief duration of smoked DMT makes it very different to manage in a therapeutic context — there is limited time for therapeutic processing during the experience itself, which is why most clinical research focuses on psilocybin or ayahuasca rather than standalone DMT. 5-MeO-DMT (found in the Bufo alvarius toad) lasts 15–45 minutes and is increasingly being explored in therapeutic contexts for its brief but extremely intense nature.

Which is more legal — psilocybin or DMT?

Neither is fully legal in the United States at the federal level, but psilocybin has made significantly more legal progress. Oregon launched legal psilocybin service centers in 2023, and Colorado followed with licensed facilitator programs in 2025. Several U.S. cities have decriminalized psilocybin possession. Australia’s Therapeutic Goods Administration (TGA) approved psilocybin as a prescription medicine for treatment-resistant depression in 2023. DMT, by contrast, has not been the subject of any state-level legalization or decriminalization in the United States. It remains Schedule I federally. Ayahuasca, which contains DMT, has some religious exemption status in the U.S. through court rulings protecting certain religious organizations, but this does not extend to general therapeutic use.

Which has more clinical evidence — psilocybin or DMT?

Psilocybin has dramatically more clinical research behind it. As of 2025, it has completed multiple Phase 2 and Phase 2b trials for treatment-resistant depression, end-of-life anxiety, alcohol use disorder, and major depressive disorder — primarily through Johns Hopkins, COMPASS Pathways, NYU, and Imperial College London. Oregon’s legal program provides real-world data from thousands of facilitated sessions annually. DMT’s clinical research is in much earlier stages. Ayahuasca has been studied in observational and open-label contexts in Brazil and Canada with promising results for PTSD and depression, but controlled trial data is limited. Synthetic short-acting DMT derivatives are entering early clinical trials — notably through Small Pharma in the UK, which has published Phase 1 data for IV DMT combined with psychotherapy for depression — but clinical evidence for standalone DMT therapy remains sparse compared to psilocybin.